Peptimize

Early signal

World's most advanced GLP-1 tracker and peptide companion

Launched 1d ago

Signal

Velocity

What this means

10%Vote pace is below typical for Consumer App.

Running at 10% of comparable launches.

+821%Launching in a 821% WoW growing category.

Android had 129 launches this week vs 14 last.

15Founder Conviction Index: 15 — low signal.

Few of the conviction sub-signals (reputation, velocity, buyer-intent, tagline clarity) are firing yet.

Prediction

Top-5 finish probability

today

Projected end-of-day votes

5range 4–7

Trajectory

stable

Vote pace holding steady.

Speed vs peers

0.1×

24 Consumer App launches

About

Take charge of your GLP-1 and peptide routine. Track Mounjaro, Ozempic, Wegovy and Zepbound doses, weight, appetite and side effects. Spot patterns with Pro on iOS. Built by a GLP-1 user. Health records stay on your device.

AI Summary

Peptimize is a GLP-1 and peptide tracking app that allows users to monitor doses, weight, appetite, and side effects for medications like Mounjaro and Ozempic. The app is available on iOS and Android, ensuring health records remain private on the user's device.

Attention & discussion velocity

Performance

Velocity0

Vote pace vs average

Momentum0

Sustained over 6h

Virality0

Spread × engagement

Engagement—

not measured

Signal sources

2 of 6 active

Launch tracking4 readings since we picked it up
AI analysisConsumer App
Comment intelligencethread not yet analysed
Outside discussionnot checked — domain is a storefront or shared
Revenue signalsno match on this domain
Editorial scoringbelow the signal threshold for this pass

A source that found nothing is a measurement. A source that has not run is a gap. Neither means the launch lacks the thing.